Sterility Testing Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Description

Sterility Testing Market Size is anticipated to be valued at USD 972.6 Million in 2021 and is expanded to grow at a significant CAGR of 10.9% over 2022-2028. Sterility testing is a critical aspect of GMP microbiology testing for sterile pharmaceuticals, medical equipment, and materials to verify their safety. During the sterilization validation procedure, as well as for routine release testing, sterility testing is essential. Stringent government regulations and an increased number of drug launches are boosting the growth of the global sterility testing market. For instance, the FDA issues a final rule on sterility testing of biological products, providing greater flexibility for developing sterility test methods. Furthermore, specific safety concerns associated with the products, which generally arise from the manufacturing process and rising demand for the sterility of the products, are driving the global sterility testing market. Increased pharmaceutical outsourcing creates opportunities for the key market players. Based on product type reagent and kits segment holds the largest share. The growth of this segment is due to the availability of a wide range of products that helps in minimizing the risk of false-negative and false-positive results. The growing demand for reagents and kits is also expected to drive the growth of this segment. Based on application, pharmaceutical and biological manufacturing recorded the highest share in 2021.

Recent Market Developments:

In June 2021, Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion.

In November 2020, the life science company Sartorius successfully closed the acquisition of the Slovenian purification specialist BIA Separations.